Evidence map›Paper›PMID 34642383›Full record

ArticleScientific reports2021

hSSB2 (NABP1) is required for the recruitment of RPA during the cellular response to DNA UV damage.

Didier Boucher, Ruvini Kariawasam, Joshua Burgess, Adrian Gimenez, Tristan E Ocampo, Blake Ferguson, Ali Naqi, Graeme J Walker, Emma Bolderson, Roland Gamsjaeger and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Didier BoucherCancer & Ageing Research Program, Centre for Genomics and Personalised Health at the Translational Research Institute (TRI), Queensland University of Technology (QUT), Brisbane, Australia.
Ruvini KariawasamSchool of Science and Health, Western Sydney University, Penrith, NSW, 2751, Australia.
Joshua BurgessCancer & Ageing Research Program, Centre for Genomics and Personalised Health at the Translational Research Institute (TRI), Queensland University of Technology (QUT), Brisbane, Australia.
Adrian GimenezSchool of Life and Environmental Sciences, University of Sydney, Sydney, NSW, 2006, Australia.
Tristan E OcampoSchool of Life and Environmental Sciences, University of Sydney, Sydney, NSW, 2006, Australia.
Blake FergusonDrug Discovery Group, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.
Ali NaqiDepartment of Chemistry, Pennsylvania State University, University Park, USA.
Graeme J WalkerDiamantina Institute, University of Queensland, Woolloongabba, QLD, 4102, Australia.
Emma BoldersonCancer & Ageing Research Program, Centre for Genomics and Personalised Health at the Translational Research Institute (TRI), Queensland University of Technology (QUT), Brisbane, Australia.
Roland GamsjaegerSchool of Science and Health, Western Sydney University, Penrith, NSW, 2751, Australia.
Kenneth J O'ByrneCancer & Ageing Research Program, Centre for Genomics and Personalised Health at the Translational Research Institute (TRI), Queensland University of Technology (QUT), Brisbane, Australia.
Liza CubedduSchool of Science and Health, Western Sydney University, Penrith, NSW, 2751, Australia. L.Cubeddu@westernsydney.edu.au.
Kum Kum KhannaSignal Transduction Group, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia. KumKum.Khanna@qimrberghofer.edu.au.
Derek J RichardCancer & Ageing Research Program, Centre for Genomics and Personalised Health at the Translational Research Institute (TRI), Queensland University of Technology (QUT), Brisbane, Australia. derek.richard@qut.edu.au.
Queensland University of Technology · AUThe University of Sydney · AUQIMR Berghofer Medical Research Institute · AUWestern Sydney University · AUPennsylvania State University · USPrincess Alexandra Hospital · AUThe University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maintenance of genomic stability is critical to prevent diseases such as cancer. As such, eukaryotic cells have multiple pathways to efficiently detect, signal and repair DNA damage. One common form of exogenous DNA damage comes from ultraviolet B (UVB) radiation. UVB generates cyclobutane pyrimidine dimers (CPD) that must be rapidly detected and repaired to maintain the genetic code. The nucleotide excision repair (NER) pathway is the main repair system for this type of DNA damage. Here, we determined the role of the human Single-Stranded DNA Binding protein 2, hSSB2, in the response to UVB exposure. We demonstrate that hSSB2 levels increase in vitro and in vivo after UVB irradiation and that hSSB2 rapidly binds to chromatin. Depletion of hSSB2 results in significantly decreased Replication Protein A (RPA32) phosphorylation and impaired RPA32 localisation to the site of UV-induced DNA damage. Delayed recruitment of NER protein Xeroderma Pigmentosum group C (XPC) was also observed, leading to increased cellular sensitivity to UVB. Finally, hSSB2 was shown to have affinity for single-strand DNA containing a single CPD and for duplex DNA with a two-base mismatch mimicking a CPD moiety. Altogether our data demonstrate that hSSB2 is involved in the cellular response to UV exposure.

Indexed as

DNA RepairAnimalsCell LineChromatinDNA-Binding ProteinsDNA DamageGene Expression RegulationHeLa CellsHumansPhosphorylationReplication Protein AUltraviolet RaysUp-RegulationChromatinDNA-Binding ProteinsReplication Protein ARPA2 protein, humanSSBP2 protein, human

Identifiers

PMID34642383
PMCPMC8511049
OpenAlexW3206880221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.